Clinical Trial Update: Application of tDCS Stimulation in Controlling Refractory Status Epilepticus [NA]

View source ↗

Summary

A clinical trial is evaluating transcranial direct current stimulation (tDCS) to control refractory status epilepticus and is currently recruiting in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Refractory Status Epilepticus | NA | Status: RECRUITING